New uses of a 5-ht4 receptor agonist
Номер патента: EP3866800A1
Опубликовано: 25-08-2021
Автор(ы): Abdul Rasheed Mohammed, Anil Karbhari Shinde, Gopinadh Bhyrapuneni, Pradeep Jayarajan, Ramakrishna Nirogi, Venkata Ramalingayya Grandhi, VENKATESWARLU Jasti, Vijay BENADE
Принадлежит: SUVEN LIFE SCIENCES LTD
Опубликовано: 25-08-2021
Автор(ы): Abdul Rasheed Mohammed, Anil Karbhari Shinde, Gopinadh Bhyrapuneni, Pradeep Jayarajan, Ramakrishna Nirogi, Venkata Ramalingayya Grandhi, VENKATESWARLU Jasti, Vijay BENADE
Принадлежит: SUVEN LIFE SCIENCES LTD
Реферат: The present invention relates to new uses of a 5-HT4 receptor agonist, specifically Isopropyl-3 - { 5- [ 1 -(3 -methoxypropyl) piperidin-4-yl] - [ 1,3,4] oxadiazol-2-yl } - 1 H- indazole (Compound- 1) or a pharmaceutically acceptable salts thereof, for the treatment of dementia due to menopause, senile dementia, cognitive deficits associated with schizophrenia, depression, chemotherapy-induced cognitive impairment, and behavioral and psychological symptoms of dementia such as apathy/indifference, agitation, aggression, depression, anxiety, irritability/lability, dysphoria, aberrant motor behavior, delusions, hallucinations, elation/euphoria, psychosis, disinhibition, sleep and night time behavior disorders or appetite and eating disorders. The present invention further provides use of the said compounds in the manufacture of medicament intended for the treatment of the disorders described herein.
New uses of a 5-ht4 receptor agonist
Номер патента: CA3116650C. Автор: VENKATESWARLU Jasti,Ramakrishna Nirogi,Anil Karbhari Shinde,Pradeep Jayarajan,Gopinadh Bhyrapuneni,Abdul Rasheed Mohammed,Venkata Ramalingayya Grandhi,Vijay BENADE. Владелец: SUVEN LIFE SCIENCES LTD. Дата публикации: 2023-08-22.